Verrica Pharmaceuticals Inc.
USD6.13
-0.37 (-5.69%)
CEO
Jayson Rieger
IPO Date
2018-06-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.14
Prev. Close
$6.50
Day Low
$6.09
Day High
$6.51
52W Low
$3.28
52W High
$9.82
Market Cap
$0.07B
Volume
0.02M
| -0.5 |
| 31 Dec 2023 | FY | 85.4% | -1307.5% | -339.0% | -82.1% | 2.30 | 4.55 | -5.0 |
| 31 Dec 2022 | FY | 92.0% | -271.1% | -61.2% | -54.8% | 0.04 | 11.31 | -3.8 |
| 31 Dec 2021 | FY | 96.1% | -292.3% | -107.6% | -43.8% | 1.33 | 1.61 | -7.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -137.9% | -61.4% | 1.13 | 1.71 | -6.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -43.4% | -41.2% | 0.00 | 19.39 | -14.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -23.1% | -22.5% | 0.00 | 36.80 | -9.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 63.3% | -49.1% | 0.00 | 14.75 | -100.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 71.8% | -351.7% | 0.00 | 1.30 | -235.1 |
| -2.7 |
| 30 Sept 2025 | Q3 | 92.3% | -1.9% | 1.6% | -0.7% | -2.10 | 1.25 | -37.3 |
| 30 Jun 2025 | Q2 | 96.1% | 1.6% | -1.2% | 0.5% | -2.22 | 1.26 | 61.6 |
| 31 Mar 2025 | Q1 | 87.7% | -283.3% | 52.4% | -23.1% | -2.28 | 1.34 | -1.1 |
| 31 Dec 2024 | Q4 | -81.7% | -4709.9% | 164.3% | -29.9% | -4.66 | 1.76 | -0.7 |
| 30 Sept 2024 | Q3 | 124.4% | 1283.5% | 67.1% | -69.4% | -1.38 | 1.34 | -0.7 |
| 30 Jun 2024 | Q2 | 89.5% | -332.0% | 129.2% | -33.0% | -3.48 | 2.36 | -5.4 |
| 31 Mar 2024 | Q1 | 70.3% | -531.4% | -1348.2% | -30.7% | 30.80 | 3.17 | -3.4 |
| 31 Dec 2023 | Q4 | -934.6% | -1238.1% | -124.5% | -30.2% | 2.30 | 4.55 | -3.4 |